Biotheus Inc. (Biotheus), a clinical-stage biotech company focusing on the discovery and development of biologics for oncology...
Solid Tumors
Anixa Biosciences Initiates Dosing in Second Cohort of Ovarian Cancer CAR-T Clinical Trial
2 min read
Anixa Biosciences, Inc. (“Anixa” or the “Company”) (NASDAQ: ANIX), a clinical-stage biotechnology company focused on the treatment and prevention of cancer,...
CDR-Life Announces FDA Clearance of IND Application for CDR404 for Treatment of Solid Tumors
1 min read
CDR-Life Inc. today announced the clearance of an Investigational New Drug (IND) application with the U.S. Food and...
MediLink Therapeutics (“MediLink”), announced today that it has entered into a worldwide collaboration and license agreement with...
Johnson & Johnson announced today the submission of a supplemental Biologics License Application (sBLA) to the U.S....
On October 26, 2023, KangaBio announced that the U.S. FDA has granted official approval for their independent R&D...
Glenmark’s new immune-oncology drug candidate granted FDA approval for Phase 1/2 clinical trial
1 min read
Glenmark Pharmaceuticals has received approval from the US Food and Drug Administration (FDA) to conduct a Phase...